HealthEquity, Inc. (NASDAQ:HQY) Receives Consensus Rating of “Buy” from Analysts

HealthEquity, Inc. (NASDAQ:HQY) has been assigned an average rating of “Buy” from the eleven analysts that are currently covering the stock, Marketbeat Ratings reports. One analyst has rated the stock with a hold rating, nine have issued a buy rating and one has issued a strong buy rating on the company. The average 12 month price target among analysts that have issued a report on the stock in the last year is $118.5455.

A number of research firms have recently issued reports on HQY. Raymond James Financial reissued a “strong-buy” rating and issued a $120.00 price target (up from $115.00) on shares of HealthEquity in a research report on Tuesday, July 8th. JMP Securities increased their price target on shares of HealthEquity from $110.00 to $117.00 and gave the stock a “market outperform” rating in a research report on Wednesday, June 4th. Bank of America raised their price objective on shares of HealthEquity from $110.00 to $125.00 and gave the company a “buy” rating in a research report on Wednesday, June 4th. Royal Bank Of Canada raised their price objective on shares of HealthEquity from $112.00 to $117.00 and gave the company an “outperform” rating in a research report on Wednesday, June 4th. Finally, Deutsche Bank Aktiengesellschaft raised their price objective on shares of HealthEquity from $98.00 to $115.00 and gave the company a “buy” rating in a research report on Thursday, June 5th.

Insider Activity at HealthEquity

In other news, EVP Elimelech Rosner sold 58,000 shares of HealthEquity stock in a transaction that occurred on Friday, June 6th. The shares were sold at an average price of $112.56, for a total value of $6,528,480.00. Following the transaction, the executive vice president owned 75,689 shares of the company’s stock, valued at $8,519,553.84. This trade represents a 43.38% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, EVP Michael Henry Fiore sold 1,794 shares of HealthEquity stock in a transaction that occurred on Monday, July 7th. The shares were sold at an average price of $101.73, for a total transaction of $182,503.62. Following the completion of the transaction, the executive vice president directly owned 53,225 shares in the company, valued at approximately $5,414,579.25. This represents a 3.26% decrease in their position. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 291,744 shares of company stock valued at $32,705,007. 1.50% of the stock is currently owned by corporate insiders.

Hedge Funds Weigh In On HealthEquity

Institutional investors have recently modified their holdings of the company. Farther Finance Advisors LLC raised its position in shares of HealthEquity by 232.4% in the second quarter. Farther Finance Advisors LLC now owns 246 shares of the company’s stock valued at $26,000 after purchasing an additional 172 shares during the period. Transce3nd LLC bought a new position in HealthEquity during the fourth quarter worth $29,000. Caitong International Asset Management Co. Ltd bought a new position in HealthEquity during the second quarter worth $33,000. WPG Advisers LLC bought a new position in HealthEquity during the first quarter worth $28,000. Finally, Versant Capital Management Inc bought a new position in HealthEquity during the first quarter worth $28,000. Institutional investors own 99.55% of the company’s stock.

HealthEquity Stock Performance

Shares of HQY opened at $89.82 on Monday. HealthEquity has a one year low of $73.84 and a one year high of $116.65. The company has a 50-day moving average of $96.78 and a two-hundred day moving average of $96.64. The stock has a market cap of $7.77 billion, a price-to-earnings ratio of 65.56, a PEG ratio of 1.41 and a beta of 0.54. The company has a debt-to-equity ratio of 0.50, a current ratio of 4.06 and a quick ratio of 4.06.

HealthEquity (NASDAQ:HQY) last announced its earnings results on Tuesday, June 3rd. The company reported $0.97 EPS for the quarter, topping the consensus estimate of $0.81 by $0.16. HealthEquity had a net margin of 9.80% and a return on equity of 11.01%. The company had revenue of $330.80 million during the quarter, compared to analysts’ expectations of $322.25 million. During the same period last year, the company posted $0.80 earnings per share. HealthEquity has set its FY 2026 guidance at 3.610-3.78 EPS. On average, equities research analysts expect that HealthEquity will post 2.32 earnings per share for the current year.

About HealthEquity

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.